A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : EC / endometrial carcinoma

[Related PubMed/MEDLINE]
Total Number of Papers: 482
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   EC  (>> Co-occurring Abbreviation)
Long Form:   endometrial carcinoma
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2019 Pathologic Prognostic Factors in Endometrial Carcinoma (Other Than Tumor Type and Grade). ---
2019 The ability of ADC measurements in the assessment of patients with stage I endometrial carcinoma based on three risk categories. ADC, DWI, MRI
2018 A Matched Analysis on the Prognostic Impact of Race on Survival Endpoints of Women with Early-Stage Endometrial Cancer. AA, DSS, LVSI, NAA, OS, RFS
2018 A network meta-analysis of comparison of operative time and complications of laparoscopy, laparotomy, and laparoscopic-assisted vaginal hysterectomy for endometrial carcinoma. LAVH, RCTs, SUCRA, WMD
2018 A Pathological Study Using 2014 WHO Criteria Reveals Poor Prognosis of Grade 3 Ovarian Endometrioid Carcinomas. HGSC, PFS
2018 Adjuvant External Radiation Impacts Outcome of Pelvis-limited Stage III Endometrial Carcinoma: A Multi-institutional Study. CRT, CT, MVA, OS, PL, RFS, RT
2018 Altered expression of lysophosphatidic acid receptors, in association with the synthesis of estrogens and androgens in type 1 endometrial cancer biology. CYP19A1, LPA, SRD5A2
2018 Are endometrial cancer radiotherapy results age related? CSS, PRT, VCR
2018 Association between RAD51 135 G/C polymorphism and risk of 3 common gynecological cancers: A meta-analysis. CI, OC, OR
10  2018 Bioinformatics analysis of key differentially expressed genes in well and poorly differentiated endometrial carcinoma. DEGs, mi
11  2018 Brain metastases in patients with low-grade endometrial carcinoma. OS
12  2018 Clinical outcomes of patients with clear cell and endometrioid ovarian cancer arising from endometriosis. CA, CCC, LNM, OS, PFS
13  2018 Contrast enhanced ultrasound in diagnosis of endometrial carcinoma and endometrial hyperplasia. CEUS, EH
14  2018 Contrast-enhanced ultrasound in the diagnosis of endometrial carcinoma: A meta-analysis. CEUS, CI, DOR, SROC
15  2018 Correlation of MACC1/c-Myc Expression in Endometrial Carcinoma with Clinical/Pathological Features or Prognosis. IHC
16  2018 Decreased expression of TFAP2B in endometrial cancer predicts poor prognosis: A study based on TCGA data. CI, GSEA, OS, TFAP-2beta
17  2018 Does Age-Adjusted Charlson Comorbidity Score Impact Survival Endpoints in Women with Federation of Gynecology and Obstetrics-Stage III Endometrial Cancer? aaCCI, DSS, OS
18  2018 Endometrial carcinoma recurrence according to race and ethnicity: An NRG Oncology/Gynecologic Oncology Group 210 Study. CIs, GOG, HRs, NHB, NHW, SES
19  2018 Establishment of a nine-gene prognostic model for predicting overall survival of patients with endometrial carcinoma. OS
20  2018 Expression of Estrogen Receptors (ER), Progesterone Receptors (PR) and HER-2/neu receptors in Endometrial Carcinoma and their associations with histological types, grades and stages of the tumor. ER, PR
21  2018 Extended duration of dilator use beyond 1year may reduce vaginal stenosis after intravaginal high-dose-rate brachytherapy. BT, VD, VS
22  2018 Fatostatin suppresses growth and enhances apoptosis by blocking SREBP-regulated metabolic pathways in endometrial carcinoma. SREBP
23  2018 Fertility Sparing Treatment in Patients With Early Stage Endometrial Cancer, Using a Combination of Surgery and GnRH Agonist: A Monocentric Retrospective Study and Review of the Literature. EIN, G1EC, GnRH
24  2018 Gene Promoter Methylation in Endometrial Carcinogenesis. AH
25  2018 Genetic polymorphisms in CDH1 are associated with endometrial carcinoma susceptibility among Chinese Han women. CDH1, htSNPs
26  2018 Hesperidin promotes programmed cell death by downregulation of nongenomic estrogen receptor signalling pathway in endometrial cancer cells. ESRI, Hsd, PS
27  2018 High preoperative Glasgow prognostic score is a negative prognostic factor for patients with endometrial carcinoma. GPS, OS, PFS
28  2018 Integrating the dysregulated inflammasome-based molecular functionome in the malignant transformation of endometriosis-associated ovarian carcinoma. CCC, EAOC, ES, GEO
29  2018 Interleukin-1 receptor-associated kinase 1 correlates with metastasis and invasion in endometrial carcinoma. IRAK1, KEGG
30  2018 Knockdown of CLDN6 inhibits cell proliferation and migration via PI3K/AKT/mTOR signaling pathway in endometrial carcinoma cell line HEC-1-B. CCK-8, Cldn6, PI3K
31  2018 Knockdown of long non-coding HOTAIR enhances the sensitivity to progesterone in endometrial cancer by epigenetic regulation of progesterone receptor isoform B. ChIP, MPA, PRB
32  2018 L1CAM further stratifies endometrial carcinoma patients with no specific molecular risk profile. L1CAM, ProMisE
33  2018 Liposomal Curcumin Targeting Endometrial Cancer Through the NF-kappaB Pathway. LC, Lipo
34  2018 LOC134466 methylation promotes oncogenesis of endometrial carcinoma through LOC134466/hsa-miR-196a-5p/TAC1 axis. lncRNA
35  2018 Long noncoding RNA HOTAIR mediates the estrogen-induced metastasis of endometrial cancer cells via the miR-646/NPM1 axis. HOX, NPM1
36  2018 Markers of the epithelial-mesenchymal transition in cells of endometrial carcinoma. EMT
37  2018 Maximizing Sentinel Lymph Node Detection: Aortic Sentinel Lymph Node Detection in Endometrial Cancer. ICG, SLNs
38  2018 MELF pattern of myometrial invasion and role in possible endometrial cancer diagnostic pathway: A systematic review of the literature. DFS, DSS, MELF
39  2018 MicroRNA 302b-3p/302c-3p/302d-3p inhibits epithelial-mesenchymal transition and promotes apoptosis in human endometrial carcinoma cells. EMT, FITC, PI, qRT-PCR
40  2018 MicroRNA-381 inhibits cell proliferation and invasion in endometrial carcinoma by targeting the IGF-1R. ERK, miRNAs
41  2018 miR-101-3p induces autophagy in endometrial carcinoma cells by targeting EZH2. TEM
42  2018 Nuclear beta-catenin and CDX2 Expression in Ovarian Endometrioid Carcinoma Identify Patients with Favorable Outcome. OCSS
43  2018 Ovarian Carcinoma Histotype: Strengths and Limitations of Integrating Morphology With Immunohistochemical Predictions. IHC
44  2018 Performance Characteristics of Endometrial Sampling in Diagnosis of Endometrial Carcinoma. AH
45  2018 Pregnancy outcomes of women who received conservative therapy for endometrial carcinoma or atypical endometrial hyperplasia. AH, MPA
46  2018 Preoperative Anemia as a Prognostic Factor in Endometrioid-Type Endometrial Carcinoma. DFS, OS
47  2018 Preoperative tumor size is associated with deep myometrial invasion and lymph node metastases and is a negative prognostic indicator for patients with endometrial carcinoma. AP, AUC, CC, MRI, OS, TV
48  2018 Prognostic Significance of Nodal Location and Ratio in Stage IIIC Endometrial Carcinoma Among a Multi-Institutional Academic Collaboration. CT, DFS, HR, LNs, OS, PC, pLN, RT
49  2018 Programmed Death Ligand 1 Expression Among 700 Consecutive Endometrial Cancers: Strong Association With Mismatch Repair Protein Deficiency. PD-L1
50  2018 Risk and prognostic factors for endometrial carcinoma after diagnosis of breast or Lynch-associated cancers-A population-based analysis. LS, MMR
51  2018 Serum calcium is a novel parameter to assess metabolic syndrome in endometrial carcinoma. EEC, FPG, HDL, LDL, NEEC, TC, TG
52  2018 Silibinin inhibits endometrial carcinoma via blocking pathways of STAT3 activation and SREBP1-mediated lipid accumulation. ---
53  2018 Studies on selected molecular factors in endometrial cancers. ---
54  2018 The PTENP1 Pseudogene, Unlike the PTEN Gene, Is Methylated in Normal Endometrium, As Well As in Endometrial Hyperplasias and Carcinomas in Middle-Aged and Elderly Females. EH
55  2018 The relationship between lncRNA PCGEM1 and STAT3 during the occurrence and development of endometrial carcinoma. qRT
56  2018 The role of EpCAM in tumor progression and the clinical prognosis of endometrial carcinoma. ---
57  2018 The role of lncRNAs in the development of endometrial carcinoma. lncRNAs
58  2018 The Yokohama system for reporting directly sampled endometrial cytology: The quest to develop a standardized terminology. ---
59  2018 Transcriptomic Characterization of Endometrioid, Clear Cell, and High-Grade Serous Epithelial Ovarian Carcinoma. CC, HGSC, PFS
60  2018 Tumor Heterogeneity in Endometrial Carcinoma: Practical Consequences. ---
61  2018 Type I Versus Type II Endometrial Cancer: Differential Impact of Comorbidity. CCI, OCCI
62  2018 Ultrastaging of Sentinel Lymph Nodes in Endometrial Carcinoma According to Use of 2 Different Methods. IHC, SLN, US
63  2018 Uterine endometrial carcinoma with DNA mismatch repair deficiency: magnetic resonance imaging findings and clinical features. MMR, MRI
64  2018 What Is the Optimal Adjuvant Treatment Sequence for Node-Positive Endometrial Cancer? Results of a National Cancer Database Analysis. CT, HR, OS, RT
65  2018 Zone Formation of Lymphocyte Infiltration at Invasive Front as a Biomarker of Prognosis in Endometrial Carcinomas. LI, OS, PFS
66  2018 [Expression and clinical significance of MIIP and PAK1 in endometrial carcinoma]. AHE, FIGO, MIIP, NE, PAK1
67  2018 [Expression of phosphoglycerate kinase 1 in endometrial carcinoma and its association with patients' outcome]. PGK1
68  2017 Aberrant MicroRNA Expression in Patients With Endometrial Cancer. CA125, HE4, miRNA
69  2017 ABO Blood Group and Endometrial Carcinoma: A Preliminary Single-Center Experience from Saudi Arabia. BMI
70  2017 Assessment of DNA Ploidy in the ProMisE molecular subgroups of endometrial cancer. ---
71  2017 Association of Hormone Receptor Expression with Survival in Ovarian Endometrioid Carcinoma: Biological Validation and Clinical Implications. AOVT, ER, HR, PR
72  2017 Autocrine Prolactin Stimulates Endometrial Carcinoma Growth and Metastasis and Reduces Sensitivity to Chemotherapy. hPRL
73  2017 Biological markers with potential clinical value in endometrial cancer - review of the literature. ---
74  2017 DICER1 regulates endometrial carcinoma invasion via histone acetylation and methylation. EMT
75  2017 Distinct molecular landscapes between endometrioid and nonendometrioid uterine carcinomas. CC, CS, USC
76  2017 DNMT1 regulates human endometrial carcinoma cell proliferation. CCK-8, DNMT1, NF-kappaBIA
77  2017 DPPIV promotes endometrial carcinoma cell proliferation, invasion and tumorigenesis. DPP-IV, HIF1A, VEGF-A
78  2017 Effect of Momordica charantia protein on proliferation, apoptosis and the AKT signal transduction pathway in the human endometrial carcinoma Ishikawa H cell line in vitro. ---
79  2017 Endoplasmic reticulum stress-mediated membrane expression of CRT/ERp57 induces immunogenic apoptosis in drug-resistant endometrial cancer cells. DOX, ER
80  2017 Estrogen and insulin synergistically promote type 1 endometrial cancer progression. ORs
81  2017 Evaluation of endometrial carcinoma prognostic immunohistochemistry markers in the context of molecular classification. BMI, CI, DSS, ER, HR, IHC, L1CAM, LVSI, OS, POLE, PR, ProMisE, PTEN, WT
82  2017 Expression and clinical significance of ARTN and MMP-9 in endometrial carcinoma. ARTN, MMP-9
83  2017 Expression of EZH2 in endometrial carcinoma and its effects on proliferation and invasion of endometrial carcinoma cells. EZH2
84  2017 Expression Profiles of Endometrial Carcinoma by Integrative Analysis of TCGA Data. DEGs, DEMs, TFs
85  2017 Fertility Preserved Hysteroscopic Approach for the Treatment of Stage Ia Endometrioid Carcinoma. ---
86  2017 Gonadotropin-Releasing Hormone Agonist Combined With a Levonorgestrel-Releasing Intrauterine System or Letrozole for Fertility-Preserving Treatment of Endometrial Carcinoma and Complex Atypical Hyperplasia in Young Women. CAH, CR, GnRHa
87  2017 Haemoglobin monitoring in endometrial cancer patients undergoing radiotherapy. EBRT, Hb, HDR-BT, OS, RT
88  2017 Hypomethylation associated enhanced transcription of trefoil factor-3 mediates tamoxifen-stimulated oncogenicity of ER+ endometrial carcinoma cells. BC, si, TAM, TFF3
89  2017 Impact of body mass index and operative approach on surgical morbidity and costs in women with endometrial carcinoma and hyperplasia. BMI, MIS
90  2017 Increase in proteins involved in mitochondrial fission, mitophagy, proteolysis and antioxidant response in type I endometrial cancer as an adaptive response to respiratory complex I deficiency. ---
91  2017 Influence of Comorbidity on the Risk of Death: A Single Institution Study of 1132 Women With Early-stage Uterine Cancer. aaCCI, DSS, LVSI, OS, RFS
92  2017 Interobserver Agreement in Endometrial Carcinoma Histotype Diagnosis Varies Depending on The Cancer Genome Atlas (TCGA)-based Molecular Subgroup. EDM, MMR, p53wt, POLE, SC
93  2017 Is Older Age a Real Adverse Prognostic Factor in Women With Early-Stage Endometrial Carcinoma? A Matched Analysis. DSS, LVSI, OS
94  2017 L1CAM and HER2 Expression in Early Endometrioid Uterine Cancer. ---
95  2017 Long non-coding RNA LINC00672 contributes to p53 protein-mediated gene suppression and promotes endometrial cancer chemosensitivity. lincRNAs
96  2017 Long non-coding RNA TUG1 promotes endometrial cancer development via inhibiting miR-299 and miR-34a-5p. lncRNAs, TUG1
97  2017 MicroRNA-29b Inhibits Angiogenesis by Targeting VEGFA through the MAPK/ERK and PI3K/Akt Signaling Pathways in Endometrial Carcinoma. IHC, miR-29b, MVD
98  2017 MicroRNA-424/E2F6 feedback loop modulates cell invasion, migration and EMT in endometrial carcinoma. miR-424
99  2017 MiR-106a promotes tumor growth, migration, and invasion by targeting BCL2L11 in human endometrial adenocarcinoma. ---
100  2017 miR-944 acts as a prognostic marker and promotes the tumor progression in endometrial cancer. CADM2, FIGO, miR-944